Wordt geladen...
SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II–III Diffuse Gliomas
BACKGROUND: Diffuse gliomas, grades II and III, hereafter called lower-grade gliomas (LGG), have variable, difficult to predict clinical courses, resulting in multiple studies to identify prognostic biomarkers. The purpose of this study was to assess expression or methylation of the homeobox family...
Bewaard in:
| Gepubliceerd in: | EBioMedicine |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5264450/ https://ncbi.nlm.nih.gov/pubmed/27840009 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2016.10.040 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|